-
A fight is brewing over requirements for annual fit-testing of filtering face-piece respirators to protect against TB. Opponents to annual fit-testing at hospitals have flooded the U.S.
-
Two years after needle safety became a mandate nationwide, hospitals face what may be their greatest challenge: keeping the momentum.
-
The Joint Commission on Accreditation of Healthcare Organizations has proposed a new infection control standard. As part of emergency management activities, organizations should prepare to respond to epidemics or infections likely to require expanded care capabilities over an extended period of time.
-
The flu season may be coming to a close, but the push for hospitals to improve their preparedness to prevent the spread of emerging infectious diseases is just gathering steam.
-
-
Goiter literally means the enlargement of the thyroid gland, independent of its cause. Historically, this terminology specifically was reserved for a visibly enlarged thyroid gland. During the past few decades of modern medical practice, the term has come to include both visible as well as palpable thyroid enlargement. This article will review the pathophysiologic processes leading to goiter formation and will provide a logical approach to the diagnosis and management of different entities, the end result of which is an enlarged thyroid gland.
-
-
Can women who are breast-feeding use a levonorgestrel intrauterine system? What is the impact of fluconazole (Diflucan, Pfizer; New York City), an oral medication used to treat vaginal yeast infections, on oral contraceptive (OC) efficacy?
-
Women now rely on contraception in such new forms as a transdermal patch and a vaginal ring. In fact, about 75% of readers participating in the 2003 Contraceptive Technology Update Contraception Survey say their facilities are offering these birth control options. What if women could get reliable birth control from a spray-on application to the skin?
-
A pill designed to prevent unintended pregnancy and birth defects is moving closer to commercial reality following a Food and Drug Administration (FDA) advisory committees unanimous vote to back such a combination product.
